MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Diagnosis of GLUT1 Deficiency Syndrome in Adulthood

A. Taneja, T. Thomas (Dallas, USA)

Meeting: 2025 International Congress

Keywords: Dystonia: Genetics

Category: Rare Neurometabolic Diseases

Objective: To present a case of GLUT1 deficiency syndrome diagnosed in adulthood emphasizing the need to keep this diagnosis in differential for adult patients with seizures and movement disorders. 

Background: GLUT1 deficiency syndrome (GLUT1-DS) is a rare metabolic disorder caused by mutations in the SLC2A1 gene, impairing glucose transport across the blood-brain barrier. Early recognition and initiation of a ketogenic diet are critical for symptom control. However, delayed diagnoses can lead to prolonged ineffective treatment, worsening neurological dysfunction

Method:

A 37-year-old female with a longstanding epilepsy diagnosis presented with progressive dystonia and worsening motor symptoms. Her history included seizure-like episodes from infancy, delayed developmental milestones, and poor response to antiepileptic drugs (AEDs). Over time, she developed dystonic posturing, limb stiffness, and episodic loss of motor control. Multiple EEGs remained inconclusive, and a movement disorder diagnosis led to treatment with carbidopa-levodopa and other medications, yielding only partial relief. Genetic testing for SLC2A1 confirmed GLUT1-DS. A ketogenic diet, providing 70–80% of calories from fat, resulted in significant motor improvement and reduced episode frequency.

Results: This case underscores the diagnostic challenges of GLUT1-DS, particularly in adults with epilepsy and movement disorders. Misdiagnosis delays appropriate treatment, prolonging disability. While GLUT1-DS is typically recognized in infancy, this case highlights the need to consider it in patients with refractory epilepsy, dystonia, or atypical movement disorders. Importantly, dietary intervention remains beneficial even when initiated in adulthood, improving quality of life and neurological function.

Conclusion: Early genetic testing for GLUT1-DS should be considered in patients with unexplained epilepsy and movement disorders to optimize management with a ketogenic diet, regardless of age at diagnosis.

To cite this abstract in AMA style:

A. Taneja, T. Thomas. Diagnosis of GLUT1 Deficiency Syndrome in Adulthood [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/diagnosis-of-glut1-deficiency-syndrome-in-adulthood/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/diagnosis-of-glut1-deficiency-syndrome-in-adulthood/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley